chartexchange

PEN
Penumbra, Inc.
stockNYSE

At CloseNov 18, 2026 3:59:54 PM EST
320.44USD+0.417%(+1.33)214,392
After-hoursNov 18, 2026 4:10:30 PM EST
320.60USD+0.050%(+0.16)
Loading…
Loading…
Healthcare
Medical Devices
CEO
Adam Elsesser
HQ
Alameda, CA, USA
Previous Close
$319.11
Beta
0.19
52-Week High
$362.41 2026-01-21
52-Week Low
$276.72 2025-11-19
SMA 50
$320.13
SMA 200
$325.16
Avg. Vol 10D
274,374
Avg. Vol 30D
368,274
Avg. Vol 90D
353,263
Relative Vol
0.58
38.30M
1.4700%
9,178
PEN Profile

penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.

PEN Performance
PeriodPriceDateChangeBeta
1W320.772026-11-12-0.05%0.266
1M322.412026-10-19-0.56%0.130
3M326.842026-08-19-1.91%0.123
6M326.552026-05-19-1.82%0.083
1Y283.152025-11-19+13.23%0.188
2Y237.112024-11-19+35.21%—
5Y262.022021-11-19+22.36%0.937
PEN Stock Summary

Penumbra, Inc. (NYSE:PEN) stock price today is $320.60, and today's volume is 214,392. PEN is up 0.467% today. The 30 day average volume is 368,274. PEN market cap is $12.64B with 39.41M shares outstanding.